Why the study?
Ventricular tachycardia following durable LVAD implantation is challenging, carries significant morbidity and mortality, and has substantially varying etiology and management.
Does bedside stellate ganglion block control drug-resistant VT storm in patients following LVAD implantation?
Design
Case report
Authors
Loading...
Stellate ganglion block may durably control refractory post-LVAD VT storm; hypothesis-generating and requires prospective validation before broader adoption.
Does bedside stellate ganglion block control drug-resistant VT storm in patients following LVAD implantation?
Stellate ganglion block can be an effective, less invasive, bedside intervention for terminating refractory VT storm in LVAD patients.
Sbrocchi et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: